<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Tumors of female reproductive system</journal-id><journal-title-group><journal-title xml:lang="en">Tumors of female reproductive system</journal-title><trans-title-group xml:lang="ru"><trans-title>Опухоли женской репродуктивной системы</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1994-4098</issn><issn publication-format="electronic">1999-8627</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">293</article-id><article-id pub-id-type="doi">10.17650/1994-4098-2009-0-1-2-63-67</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>GYNECOLOGY. PROBLEM</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ГИНЕКОЛОГИЯ. ПРОБЛЕМА</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">IMMUNITY IN PATIENTS WITH TROPHOBLASTIC DISEASE</article-title><trans-title-group xml:lang="ru"><trans-title>ИММУННЫЙ СТАТУС У ПАЦИЕНТОК С ТРОФОБЛАСТИЧЕСКОЙ БОЛЕЗНЬЮ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Toloknov</surname><given-names>B. O.</given-names></name><name xml:lang="ru"><surname>Толокнов</surname><given-names>Б. О.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>kad-zaira@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Slavina</surname><given-names>E. G.</given-names></name><name xml:lang="ru"><surname>Славина</surname><given-names>Е. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kadagidze</surname><given-names>Z. G.</given-names></name><name xml:lang="ru"><surname>Кадагидзе</surname><given-names>З. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Laktionov</surname><given-names>K. P.</given-names></name><name xml:lang="ru"><surname>Лактионов</surname><given-names>К. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Makhova</surname><given-names>Е. Е.</given-names></name><name xml:lang="ru"><surname>Махова</surname><given-names>Е. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Chertkova</surname><given-names>A. I.</given-names></name><name xml:lang="ru"><surname>Черткова</surname><given-names>А. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Markina</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Маркина</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow</institution></aff><aff><institution xml:lang="ru">ГУ РОНЦ им. Н.Н. Блохина РАМН, Москва</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2009-05-01" publication-format="electronic"><day>01</day><month>05</month><year>2009</year></pub-date><issue>1-2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>63</fpage><lpage>67</lpage><history><date date-type="received" iso-8601-date="2014-09-03"><day>03</day><month>09</month><year>2014</year></date><date date-type="accepted" iso-8601-date="2014-09-03"><day>03</day><month>09</month><year>2014</year></date></history><permissions><copyright-year>2009</copyright-year><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://ojrs.abvpress.ru/ojrs/article/view/293">https://ojrs.abvpress.ru/ojrs/article/view/293</self-uri><abstract xml:lang="en"><p>The investigation included 39 female patients with different forms of trophoblastic disease whose immunity was studied by the cur- rently available procedures. The patients were divided into 2 groups. Group 1 comprised 29 patients with a history of hydatidiform mole, who received no chemotherapy (CT) since an analysis of the data did not show the presence of a trophoblastic tumor. Group 2 consisted of 10 patients with a verified trophoblastic tumor who received CT with various drugs. The patients with trophoblastic disease were found to have some abnormal immunological parameters; however, they differ little in patients with the malignant and benign course of the disease and cannot serve as a prognostic factor. Activated lymphocytes were substantially increased in both groups, suggesting an active immune response to antigen-foreign cells expressing along with parenteral antigens. The patients with hydatidiform mole have the sign to be further studied, that is a reduction in the count of СD25-positive Т lymphocytes, pos- sibly, suppressor cells.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>suppressor cells</kwd><kwd>trophoblastic disease</kwd><kwd>hydatidiform mole</kwd><kwd>chemotherapy</kwd><kwd>immunity</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>клетки-супрессоры</kwd><kwd>трофобластическая болезнь</kwd><kwd>пузырный занос</kwd><kwd>химиотерапия</kwd><kwd>иммунитет</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Григорова Т.М. Трофобластическая болезнь. М.: Медицина, 1985.</mixed-citation><mixed-citation xml:lang="ru">Григорова Т.М. Трофобластическая болезнь. М.: Медицина, 1985.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Nagymanyoki Z., Callahan M.J., Parast M.M. et al. Immune cell Profiling in normal pregnancy, partial and complet molar pregnancy. Gynecjl Omcol 2007;107(2):292—7.</mixed-citation><mixed-citation xml:lang="ru">Nagymanyoki Z., Callahan M.J., Parast M.M. et al. Immune cell Profiling in normal pregnancy, partial and complet molar pregnancy. Gynecjl Omcol 2007;107(2):292—7.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Wang X., Fu S., Freedman R.S. et al. Immunobiology of gestational trophoblastic diseases. Int J Gynecol Cancer 2006;16(4):1500—15.</mixed-citation><mixed-citation xml:lang="ru">Wang X., Fu S., Freedman R.S. et al. Immunobiology of gestational trophoblastic diseases. Int J Gynecol Cancer 2006;16(4):1500—15.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Krishnan L., Kinsky B., Chaounat G. et al. Suppression of local and systemic GvHR by supernatants from choriocarci- noma cell lines. Cell Immunol 1993;150(2):376—84.</mixed-citation><mixed-citation xml:lang="ru">Krishnan L., Kinsky B., Chaounat G. et al. Suppression of local and systemic GvHR by supernatants from choriocarci- noma cell lines. Cell Immunol 1993;150(2):376—84.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Krishnan L., Sads S., Raghupathy R. Characterization of an immunosupressiv factor secreted by a human trophoblastderived choriocfarcinoma cell line. Cell Immunol 1995;162(2):295—308.</mixed-citation><mixed-citation xml:lang="ru">Krishnan L., Sads S., Raghupathy R. Characterization of an immunosupressiv factor secreted by a human trophoblastderived choriocfarcinoma cell line. Cell Immunol 1995;162(2):295—308.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Boyum A. Separation of blood leuco- cytes. Granulicytes and lymphocytes. Tiss antigen 1974;4:269—74.</mixed-citation><mixed-citation xml:lang="ru">Boyum A. Separation of blood leuco- cytes. Granulicytes and lymphocytes. Tiss antigen 1974;4:269—74.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assay. J Immunol Method 1983;65(1): 55—60.</mixed-citation><mixed-citation xml:lang="ru">Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assay. J Immunol Method 1983;65(1): 55—60.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
